BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24244715)

  • 1. Triptolide induces growth inhibition and apoptosis of human laryngocarcinoma cells by enhancing p53 activities and suppressing E6-mediated p53 degradation.
    Zhao F; Huang W; Ousman T; Zhang B; Han Y; Clotaire DZ; Wang C; Chang H; Luo H; Ren X; Lei M
    PLoS One; 2013; 8(11):e80784. PubMed ID: 24244715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
    Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
    Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.
    Wan CK; Wang C; Cheung HY; Yang M; Fong WF
    Cancer Lett; 2006 Sep; 241(1):31-41. PubMed ID: 16316721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
    Huang M; Zhang H; Liu T; Tian D; Gu L; Zhou M
    Mol Cancer Ther; 2013 Feb; 12(2):184-94. PubMed ID: 23243057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway.
    Chang WT; Kang JJ; Lee KY; Wei K; Anderson E; Gotmare S; Ross JA; Rosen GD
    J Biol Chem; 2001 Jan; 276(3):2221-7. PubMed ID: 11053449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
    Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
    PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
    Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
    Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide induces apoptosis through extrinsic and intrinsic pathways in human osteosarcoma U2OS cells.
    Kwon HY; Kim KS; An HK; Moon HI; Kim HJ; Lee YC
    Indian J Biochem Biophys; 2013 Dec; 50(6):485-91. PubMed ID: 24772972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.
    Kiviharju TM; Lecane PS; Sellers RG; Peehl DM
    Clin Cancer Res; 2002 Aug; 8(8):2666-74. PubMed ID: 12171899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
    Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
    Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.
    Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H
    Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide interrupts rRNA synthesis and induces the RPL23‑MDM2‑p53 pathway to repress lung cancer cells.
    Wang J; Zhang ZQ; Li FQ; Chen JN; Gong X; Cao BB; Wang W
    Oncol Rep; 2020 Jun; 43(6):1863-1874. PubMed ID: 32236588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new semisynthetic 1-O-acetyl-6-O-lauroylbritannilactone induces apoptosis of human laryngocarcinoma cells through p53-dependent pathway.
    Han YY; Tang JJ; Gao RF; Guo X; Lei M; Gao JM
    Toxicol In Vitro; 2016 Sep; 35():112-20. PubMed ID: 27262408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
    Nakazato T; Sagawa M; Kizaki M
    Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
    Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
    Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
    Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
    Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide.
    Wang X; Matta R; Shen G; Nelin LD; Pei D; Liu Y
    J Mol Med (Berl); 2006 May; 84(5):405-15. PubMed ID: 16385419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway.
    Zhao X; Zhang Q; Chen L
    Oncol Rep; 2016 Sep; 36(3):1499-505. PubMed ID: 27461934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.